All companies › ENOV

ENOV · Enovis CORP

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys3
Open-market sells0
Total purchased$399,591
Unique insiders buying2
Most senior buyerCEO
Avg price paid$19.37
Research cases0
Last filing2026-09-04

Average price paid is weighted by shares, so a large purchase counts for more than a small one. It is what insiders reported paying, not a target or a fair value.

Insider flow: Buying only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-02 — Engert Oliver · bought 2,458 @ $20.32 2026-09-03 — Engert Oliver · bought 5,140 @ $19.46 2026-09-04 — McDonald Damien · bought 13,035 @ $19.15
2026-09-022026-09-04

Insider cost basis

Share-weighted average price across 3 reported purchases, with the full range of prices paid. Purchases only — averaging a sale into an "insider cost" would describe a price nobody paid.

$19.15 $20.32
$19.37 weighted average insider purchase price

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Engert Oliver Chief Administrative Officer
McDonald Damien Chief Executive Officer
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $ENOV is the reading of them — and for this company, that is what the list below says it is, no more.

  • Insider cost basisShare-weighted average price paid across the 3 reported purchases, with the full range, against the current price.
  • Insider participationWho bought, how often, and how the buying is distributed across the people filing — one person repeating is not several agreeing.
  • Transaction timelineThe [{'transaction_date': '2026-09-04', 'insider_name': 'McDonald Damien', 'insider_title': 'Chief Executive Officer', 'transaction_type': 'Open-market buy', 'shares': 13035.0, 'price': 19.15, 'value': 249620.25, 'is_buy': True}, {'transaction_date': '2026-09-03', 'insider_name': 'Engert Oliver', 'insider_title': 'Chief Administrative Officer', 'transaction_type': 'Open-market buy', 'shares': 5140.0, 'price': 19.46, 'value': 100024.4, 'is_buy': True}, {'transaction_date': '2026-09-02', 'insider_name': 'Engert Oliver', 'insider_title': 'Chief Administrative Officer', 'transaction_type': 'Open-market buy', 'shares': 2458.0, 'price': 20.32, 'value': 49946.56, 'is_buy': True}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for ENOV today: no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.